COX5A encodes cytochrome c oxidase subunit 5A, a crucial component of mitochondrial complex IV (cytochrome c oxidase, COX). Complex IV is the terminal enzyme of the mitochondrial electron transport chain and is responsible for oxidizing cytochrome c and reducing oxygen to water, a process essential for aerobic ATP production.
COX5A is a nuclear-encoded subunit that is imported into mitochondria. It is specifically expressed in tissues with high oxidative metabolism, including:
- Brain (neurons, especially)
- Heart
- Skeletal muscle
- Liver
COX5A is part of the core structure of complex IV:
- Contains the cytochrome c binding site
- Participates in electron transfer from cytochrome c to the binuclear center
- Essential for proton pumping across the inner mitochondrial membrane
- Heme a and heme a3 are cofactors in the catalytic center
- Expression is regulated by mitochondrial biogenesis factors (PGC-1α)
- Subject to retrograde signaling from mitochondria to nucleus
COX5A expression is particularly high in:
- Neurons — high energy demand for synaptic function
- Cardiac muscle — continuous contraction
- Skeletal muscle — exercise-induced mitochondrial biogenesis
- Reduced COX activity in neurons and platelets
- Mitochondrial dysfunction is an early event in AD pathogenesis
- Impaired oxidative phosphorylation leads to energy deficit
- Correlation with cognitive decline
- Complex IV deficiency in substantia nigra neurons
- Mitochondrial complex I is primarily affected, but complex IV is also impaired
- Cell death due to energy failure
- Rare but severe
- Can cause Leigh syndrome or encephalomyopathy
- Presents with:
- Lactic acidosis
- Developmental regression
- Motor symptoms
COX5A expression patterns:
- Brain: Highest in cortex, hippocampus, cerebellum
- Heart: Very high (cardiac muscle)
- Skeletal muscle: Exercise-responsive
- Liver: Moderate expression
Expression is regulated by:
- Thyroid hormone
- PGC-1α (mitochondrial biogenesis)
- Hypoxia-inducible factors
- Parikh et al., Mitochondrial dysfunction in Alzheimer's disease (2009)
- Gandhi et al., COX deficiency in neurodegeneration (2012)
- Stryber et al., Cytochrome c oxidase in AD brain (2021)